A detailed history of Apollon Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Apollon Financial, LLC holds 896 shares of AMGN stock, worth $250,942. This represents 0.08% of its overall portfolio holdings.

Number of Shares
896
Previous 843 6.29%
Holding current value
$250,942
Previous $263 Million 9.63%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$309.38 - $337.38 $16,397 - $17,881
53 Added 6.29%
896 $289 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $7,619 - $9,259
-29 Reduced 3.33%
843 $263 Million
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $5,108 - $6,166
19 Added 2.23%
872 $248 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $218,112 - $246,056
853 New
853 $246 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Apollon Financial, LLC Portfolio

Follow Apollon Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Financial, LLC with notifications on news.